250 related articles for article (PubMed ID: 28441892)
1. Changes in blood and urinary cadmium levels and bone mineral density according to osteoporosis medication in individuals with an increased cadmium body burden.
Eom SY; Yim DH; Hong SM; Kim YD; Kim H; Choi BS; Park JD; Park CH; Kim GB; Yu SD
Hum Exp Toxicol; 2018 Apr; 37(4):350-357. PubMed ID: 28441892
[TBL] [Abstract][Full Text] [Related]
2. Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV.
McComsey GA; Kendall MA; Tebas P; Swindells S; Hogg E; Alston-Smith B; Suckow C; Gopalakrishnan G; Benson C; Wohl DA
AIDS; 2007 Nov; 21(18):2473-82. PubMed ID: 18025884
[TBL] [Abstract][Full Text] [Related]
3. Are oral bisphosphonates effective in improving lumbar bone mineral density in breast cancer survivors with osteopenia or osteoporosis?
Sawka AM; Ioannidis G; Papaioannou A; Thabane L; Olszynski WP; Brown JP; Hanley DA; Murray TM; Josse RG; Sebaldt RJ; Petrie A; Tenenhouse A; Goldsmith CH; Boulos P; Kouroukis T; Adachi JD
J Obstet Gynaecol Can; 2005 Aug; 27(8):759-64. PubMed ID: 16287007
[TBL] [Abstract][Full Text] [Related]
4. Superiority of a combined treatment of Alendronate and Alfacalcidol compared to the combination of Alendronate and plain vitamin D or Alfacalcidol alone in established postmenopausal or male osteoporosis (AAC-Trial).
Ringe JD; Farahmand P; Schacht E; Rozehnal A
Rheumatol Int; 2007 Mar; 27(5):425-34. PubMed ID: 17216477
[TBL] [Abstract][Full Text] [Related]
5. Osteoporosis and thyrotropin-suppressive therapy: reduced effectiveness of alendronate.
Panico A; Lupoli GA; Fonderico F; Marciello F; Martinelli A; Assante R; Lupoli G
Thyroid; 2009 May; 19(5):437-42. PubMed ID: 19415993
[TBL] [Abstract][Full Text] [Related]
6. Changes in the RANK ligand/osteoprotegerin system are correlated to changes in bone mineral density in bisphosphonate-treated osteoporotic patients.
Dobnig H; Hofbauer LC; Viereck V; Obermayer-Pietsch B; Fahrleitner-Pammer A
Osteoporos Int; 2006; 17(5):693-703. PubMed ID: 16435076
[TBL] [Abstract][Full Text] [Related]
7. Whole body vibration versus magnetic therapy on bone mineral density in elderly osteoporotic individuals.
Shanb AA; Youssef EF; Muaidi QI; Alothman AA
J Back Musculoskelet Rehabil; 2017 Aug; 30(4):903-912. PubMed ID: 28453453
[TBL] [Abstract][Full Text] [Related]
8. Effect of a nutritional supplementation on bone health in Chilean elderly subjects with femoral osteoporosis.
Bunout D; Barrera G; Leiva L; Gattas V; de la Maza MP; Haschke F; Steenhout P; Klassen P; Hager C; Offord E; Hirsch S
J Am Coll Nutr; 2006 Jun; 25(3):170-7. PubMed ID: 16766774
[TBL] [Abstract][Full Text] [Related]
9. Alendronate, vitamin D, and calcium for the treatment of osteopenia/osteoporosis associated with HIV infection.
Mondy K; Powderly WG; Claxton SA; Yarasheski KH; Royal M; Stoneman JS; Hoffmann ME; Tebas P
J Acquir Immune Defic Syndr; 2005 Apr; 38(4):426-31. PubMed ID: 15764959
[TBL] [Abstract][Full Text] [Related]
10. Differences in the susceptibility to cadmium-induced renal tubular damage and osteoporosis according to sex.
Kim YD; Yim DH; Eom SY; Moon SI; Park CH; Kim GB; Yu SD; Choi BS; Park JD; Kim H
Environ Toxicol Pharmacol; 2014 Jul; 38(1):272-8. PubMed ID: 24975448
[TBL] [Abstract][Full Text] [Related]
11. Comparison between different bone treatments on areal bone mineral density (aBMD) and bone microarchitectural texture as assessed by the trabecular bone score (TBS).
Di Gregorio S; Del Rio L; Rodriguez-Tolra J; Bonel E; García M; Winzenrieth R
Bone; 2015 Jun; 75():138-43. PubMed ID: 25571842
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D status and bone mineral density changes during alendronate treatment in postmenopausal osteoporosis.
Roux C; Binkley N; Boonen S; Kiel DP; Ralston SH; Reginster JY; Pong A; Rosenberg E; Santora A;
Calcif Tissue Int; 2014 Feb; 94(2):153-7. PubMed ID: 23912950
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D levels: its relationship to bone mineral density response and disease activity in premenopausal Malaysian systemic lupus erythematosus patients on corticosteroids.
Yeap SS; Othman AZ; Zain AA; Chan SP
Int J Rheum Dis; 2012 Feb; 15(1):17-24. PubMed ID: 22324943
[TBL] [Abstract][Full Text] [Related]
14. The effects of parathyroid hormone, alendronate, or both in men with osteoporosis.
Finkelstein JS; Hayes A; Hunzelman JL; Wyland JJ; Lee H; Neer RM
N Engl J Med; 2003 Sep; 349(13):1216-26. PubMed ID: 14500805
[TBL] [Abstract][Full Text] [Related]
15. Alendronate in combination with calcium and vitamin D prevents bone loss after orthotopic liver transplantation: a prospective single-center study.
Millonig G; Graziadei IW; Eichler D; Pfeiffer KP; Finkenstedt G; Muehllechner P; Koenigsrainer A; Margreiter R; Vogel W
Liver Transpl; 2005 Aug; 11(8):960-6. PubMed ID: 16035083
[TBL] [Abstract][Full Text] [Related]
16. Temporal changes in urinary levels of cadmium, N-acetyl-β-d-glucosaminidase and β2-microglobulin in individuals in a cadmium-contaminated area.
Kim YD; Yim DH; Eom SY; Moon SI; Park CH; Kim GB; Yu SD; Choi BS; Park JD; Kim H
Environ Toxicol Pharmacol; 2015 Jan; 39(1):35-41. PubMed ID: 25434760
[TBL] [Abstract][Full Text] [Related]
17. Treatment with alendronate plus calcium, alendronate alone, or calcium alone for postmenopausal low bone mineral density.
Bonnick S; Broy S; Kaiser F; Teutsch C; Rosenberg E; DeLucca P; Melton M
Curr Med Res Opin; 2007 Jun; 23(6):1341-9. PubMed ID: 17594775
[TBL] [Abstract][Full Text] [Related]
18. Secondary hyperparathyroidism due to hypovitaminosis D affects bone mineral density response to alendronate in elderly women with osteoporosis: a randomized controlled trial.
Barone A; Giusti A; Pioli G; Girasole G; Razzano M; Pizzonia M; Palummeri E; Bianchi G
J Am Geriatr Soc; 2007 May; 55(5):752-7. PubMed ID: 17493196
[TBL] [Abstract][Full Text] [Related]
19. The treatment of osteoporosis in patients with rheumatoid arthritis receiving glucocorticoids: a comparison of alendronate and intranasal salmon calcitonin.
Tascioglu F; Colak O; Armagan O; Alatas O; Oner C
Rheumatol Int; 2005 Nov; 26(1):21-9. PubMed ID: 15688191
[TBL] [Abstract][Full Text] [Related]
20. Effect of alendronate on bone mineral density in Puerto Rican males with osteoporosis.
Martinó A; Rosa J; Guzmán J; Ramírez M
P R Health Sci J; 2005 Jun; 24(2):131-5. PubMed ID: 16116930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
